Dane Johnson, MD
Urology · Saint Louis, MONPI 1730479932
Payments from drug & device makers
Across 109 payments — averaging $29.28 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boston Scientific$1K
- Endo Pharmaceuticals Inc.$603
- Calyxo, Inc.$190
- Endo USA, Inc.$154
- Coloplast$142
- Cook Medical LLC$132
- plus $517 from 13 others
What the payments were for
- Food & beverage$2,93892%
- Education$2538%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boston Scientific | 48 | $1,453 |
| Endo Pharmaceuticals Inc. | 34 | $603 |
| Calyxo, Inc. | 3 | $190 |
| Endo USA, Inc. | 4 | $154 |
| Coloplast | 2 | $142 |
| Cook Medical LLC | 2 | $132 |
| Johnson & Johnson | 2 | $94 |
| Merck | 1 | $87 |
| Uroviu Corporation | 1 | $61 |
| Photocure Inc | 1 | $44 |
| Tolmar, Inc. | 2 | $44 |
| Myriad Genetic Laboratories, Inc. | 2 | $40 |
| AstraZeneca | 1 | $35 |
| Urogen Pharma, Inc. | 1 | $25 |
| Novo Nordisk | 1 | $23 |
| Procept Biorobotics Corporation | 1 | $20 |
| 180 Medical, Inc. | 1 | $19 |
| Acerus Pharmaceuticals Corporation | 1 | $14 |
| Metuchen Pharmaceuticals | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- GENERAL ERECTILE DYSFUNCTION$235
- CVAC Aspiration System$161
- TITAN$129
- XIAFLEX$121
- Cook$118
- AMS 700$110
How this compares
$3,192 in reported general payments places this provider in the 45th percentile of 250 urology providers in Missouri.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MyrbetriqMirabegron | 12 | $5,960 |
| Testosterone | 13 | $2,488 |
| Testosterone Cypionate | 15 | $1,030 |
| Tamsulosin Hcl | 43 | $529 |
| Sildenafil Citrate | 16 | $46 |
Paid to pharmacies, not to this prescriber.
Other urology in Saint Louis
- Travis BullockSaint Louis$751K
- Michael JohnsonSaint Louis$471K
- Gregory AuffenbergSaint Louis$468K
- Gerald AndrioleSaint Louis$308K
- Hing LaiSaint Louis$173K
- Gautum AgarwalSaint Louis$111K
- Gurdarshan SandhuSaint Louis$101K
- Gregory McLennanSaint Louis$89K
- Gregory MurphySaint Louis$65K
- Charles JonesSaint Louis$55K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.